Aim To investigate the relationship between C-reactive protein, anthropometric parameters, and lipids in women in the menopausal transition. Methods This cross-sectional study included 150 women divided into three groups: premenopausal (n=50), perimenopausal (n=50), and postmenopausal (n=50). All women were interviewed, body mass index (BMI) and waist-hip ratio (WHR) values were calculated, and a blood sample was taken for laboratory analysis. The values of the lipids were determined including triglycerides, total cholesterol, and high-density lipoprotein (HDL) cholesterol, while low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) cholesterol values were obtained through formulas. The concentration of CRP was determined by immunoturbidimetry on the Architect ci8200 device. Results The BMI of postmenopausal women was significantly higher than that of premenopausal (p=0.025) and perimenopausal women (p=0.010). The ratio of the waist-hip circumference of postmenopausal women was significantly higher than the ratio of the waist-hip circumference of premenopausal women (p<0.001), as well as that of perimenopausal women (p<0.001). A significant difference in CRP concentration was found only between the postmenopausal and premenopausal groups (p=0.009). CRP significantly positively correlated with BMI in all three groups. A significant positive correlation was found between CRP and WHR in the perimenopause and in the postmenopause group. No significant correlation was found between CRP and lipid parameters in any group. Conclusion An increase in body weight or obesity in the postmenopausal period, increase in CRP concentration, and positive correlation between these parameters suggest that entering menopause could mean a potential increase in the risk of developing cardiovascular and metabolic diseases.
Slopien R, Wender-Ozegowska E, Rogowicz-Frontczak A, Meczekalski B, Zozulinska-Ziolkiewicz D, Jaremek J, et al. Anagnostis P, Lambrinoudaki I. Menopause and diabetes: EMAS clinical guide. Maturitas. 2018. p. 6–10.
2.
Juppi H, Sipilä S, Fachada V, Hyvärinen M, Cronin N, Aukee P, et al. Total and regional body adiposity increases during menopause-evidence from a follow-up study. Aging Cell. 2022. p. 13621.
3.
Ho S, Wu S, Chan S, Sham A. Menopausal transition and changes of body composition: a prospective study in Chinese perimenopausal women. Int J Obes (Lond). 2010. p. 1265–74.
4.
Han C. Roles of reactive oxygen species on insulin resistance in adipose tissue. Diabetes Metab J. 2016. p. 272–9.
5.
Trim W, Turner J, Thompson D. Parallels in immunometabolic adipose tissue dysfunction with ageing and obesity. Front Immunol. 2018. p. 169.
6.
Möller K, Ostermann A, Rund K, Thoms S, Blume C, Stahl F, et al. Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects. Prostaglandins Leukot Essent Fatty Acids. 2016. p. 39–49.
7.
Mair K, Gaw R, Maclean M. Obesity, estrogens and adipose tissue dysfunction -implications for pulmonary arterial hypertension. Pulm Circ. 2020. p. 2045894020952019.
8.
Berg G, Mesch V, Boero L, Sayegh F, Prada M, Royer M, et al. Benencia H. Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution. Horm Metab Res. 2004. p. 215–20.
9.
Ambikairajah A, Walsh E, Cherbuin N. Lipid profile differences during menopause: a review with metaanalysis. Menopause. 2019. p. 1327–33.
10.
Anagnostis P, Bitzer J, Cano A, Ceausu I, Chedraui P, Durmusoglu F, et al. Menopause symptom management in women with dyslipidemias: An EMAS clinical guide. Maturitas. 2020. p. 82–8.
11.
Khoudary E, Wang S, Brooks L, Thurston M, Derby R, Matthews C, et al. Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression. J Clin Lipidol. 2016. p. 962–9.
12.
Ko S, Kim H. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients. 2020. p. 202.
13.
Choi Y, Chang Y, Kim B, Kang D, Kwon M, Kim C, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015. p. 399–405.
14.
Bhurosy T, Jeewon R. Food habits, socioeconomic status and body mass index among premenopausal and post-menopausal women in Mauritius. J Hum Nutr Diet. 2013. p. 114–22.
15.
Giannini A, Caretto M, Genazzani A, Simoncini T. Menopause, hormone replacement therapy (HRT) and obesity. Curre Res Diabetes & Obes J. 2018. p. 555704.
16.
Ahmed H. Metabolic and hormonal changes associated with menopause. Mustansiriya Med J. 2017. p. 77–82.
17.
Hummadi M, Ahmed H, Hussien Z, Ali Z. Assessment of serum Interleukin-6 and Leptin levels in postmenopausal Iraqi women. Int J Pharm Res. 2020. p. 1.
18.
Li H, Sun R, Chen Q, Guo Q, Wang J, Lu L, et al. Association between HDL-C levels and menopause: a meta-analysis. Hormones (Athens). p. 49–59.
19.
Hamza A, Abbas M, Elfaki I, Abdalhabib E, Karar T. Assessment of plasma lipid profile among Sudanese menopausal women in Khartoum State-Sudan. Biomed Pharmacol J. 2019. p. 2037–41.
20.
Ebong I, Schreiner P, Lewis C, Appiah D, Ghelani A, Wellons M. The association between high-sensitivity C-reactive protein and hypertension in women of the Cardia study. Menopause. 2016. p. 662–8.
21.
Sites C, Toth M, Cushman M, Hommedieu L, Tchernof G, Tracy A, et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril. 2002. p. 128–35.
22.
Sharma N, Sharma R, Tewari S, Chauhan M, Bhatia A. Association of periodontal inflammation, systemic inflammation, and duration of menopausal years in postmenopausal women. Quintessence Int. 2018. p. 123–31.
23.
Tchernof A, Nolan A, Sites C, Ades P, Poehlman E. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002. p. 564–9.
24.
Chitra J, Deshpande S. An observational study to predict the risk of stroke in post-menopausal women using Hs-CRP and Qstroke. Indian J Physiother Ther. 2019. p. 139–43.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
